Radiopharm Theranostics (RDPTF) Intangibles (2023 - 2026)

Radiopharm Theranostics (RDPTF) has reported Intangibles for 4 consecutive years, with $270701.6 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Intangibles fell 9.25% year-over-year to $270701.6 in Q2 2026; TTM through Jun 2026 was $270701.6, a 9.25% decrease from a year earlier, with the FY2026 full-year figure at $259179.3, down 99.44% from the prior year.
• Intangibles was $270701.6 for Q2 2026 at Radiopharm Theranostics, down from $298278.1 in the prior quarter.
• Over five years, Intangibles peaked at $58.5 million in Q2 2023 and troughed at $270701.6 in Q2 2026.
• A 4-year average of $21.5 million and a median of $323497.2 in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles sank 99.45% in 2024 and declined 7.8% in 2025, its largest moves.
• Over 4 years, Intangibles stood at $58.5 million in 2023, then declined by 18.0% to $48.0 million in 2024, then slumped by 99.38% to $298278.1 in 2025, then slipped by 9.25% to $270701.6 in 2026.
• The last three Intangibles figures came in at $270701.6 (Q2 2026), $298278.1 (Q2 2025), and $48.0 million (Q4 2024), per Business Quant data.